Your browser doesn't support javascript.
loading
Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
Li, Betty; Lin, Jianmin; Vanroey, Melinda; Jure-Kunkel, Maria; Jooss, Karin.
Affiliation
  • Li B; Cell Genesys Inc, South San Francisco, CA 94080, USA. betty.li@cellgenesys.com
Clin Immunol ; 125(1): 76-87, 2007 Oct.
Article in En | MEDLINE | ID: mdl-17706463
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Granulocyte-Macrophage Colony-Stimulating Factor / Immunotherapy, Adoptive / Tumor Necrosis Factor Receptor Superfamily, Member 9 / Immunologic Factors / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2007 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Granulocyte-Macrophage Colony-Stimulating Factor / Immunotherapy, Adoptive / Tumor Necrosis Factor Receptor Superfamily, Member 9 / Immunologic Factors / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals Language: En Journal: Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2007 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos